Jiangsu Kanion Pharmaceutical Co. Ltd. Class ASSE: 600557

Announcement on Implementing Repurchase and Cancellation of All Remaining Restricted Stocks under the 2022 Annual Restricted Stocks Incentive Plan

· Issued by Jiangsu Kanion Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Implementing Repurchase and Cancellation of All Remaining Restricted Stocks under the 2022 Annual Restricted Stocks Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis